Multiplex Assay Kit for Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array)

LIPD; Lipase, Lipoprotein

Specificity

This assay has high sensitivity and excellent specificity for detection of Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 92-105 95
EDTA plasma(n=5) 78-105 92
heparin plasma(n=5) 92-101 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 96-103% 81-97% 84-99% 96-105%
EDTA plasma(n=5) 80-105% 99-105% 86-94% 90-102%
heparin plasma(n=5) 88-96% 82-96% 88-96% 86-95%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Diabetes Severity of Diabetes Governs Vascular Lipoprotein Lipase by Affecting Enzyme Dimerization and Disassembly PubMed: 21646389
The Korean Journal of Internal Medicine Clinical efficacy of serum lipase subtype analy-sis for the differential diagnosis of pancreatic and non-pancreatic lipase elevation Pubmed:27243230
The Journal of Lipid Research ReCavia (Guinea pig )lation of Plasma Lipid Homeostasis by Hepatic Lipoprotein Lipase in Adult Mice Pubmed:27234787
Journal of Functional Foods Polysaccharides from Cyclocarya paliurus: Chemical composition and lipid-lowering effect on rats challenged with high-fat diet 10.1016/j.jff.2017.07.020
Biotechnology Progress Mass Spectrometric Evaluation of Upstream and Downstream Process Influences on Host Cell Protein Patterns in Biopharmaceutical Products Pubmed: 30767403
arteriosclerosis thrombosis and vascular biology Integrin β3 Deficiency Results in Hypertriglyceridemia Via Disrupting LPL (Lipoprotein Lipase) Secretion Pubmed: 32237906
Clinical Nutrition ESPEN Abdominal fat distribution modulates the metabolic effects of exogenous ketones in individuals with new-onset prediabetes after acute pancreatitis: Results from a randomized placebo-controlled trial 34024503
Antioxidants Bio-Evaluation of the Wound Healing Activity of Artemisia judaica L. as Part of the Plant's Use in Traditional Medicine; Phytochemical, Antioxidant, Anti-Inflammatory … Pubmed:35204215
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA386Hu02 Recombinant Lipoprotein lipase (LPL) Positive Control; Immunogen; SDS-PAGE; WB.
RPA386Hu01 Recombinant Lipoprotein lipase (LPL) Positive Control; Immunogen; SDS-PAGE; WB.
PAA386Hu02 Polyclonal Antibody to Lipoprotein lipase (LPL) WB
PAA386Hu01 Polyclonal Antibody to Lipoprotein lipase (LPL) WB; ICC/IF
MAA386Hu22 Monoclonal Antibody to Lipoprotein lipase (LPL) Testing in progress
SEA386Hu ELISA Kit for Lipoprotein lipase (LPL) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA386Hu Multiplex Assay Kit for Lipoprotein lipase (LPL) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMA386Hu Multiplex Assay Kit for Lipoprotein lipase (LPL) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.
CGA386Hu02 cDNA of Lipoprotein lipase (LPL) PCR; Protein Expression; etc.